Used primarily in cancer treatment, this compound serves as a key intermediate in the synthesis of platinum-based antitumor drugs. Its chiral structure allows for selective interaction with DNA, enhancing the efficacy and reducing side effects in chemotherapy. It is especially valuable in developing targeted therapies for ovarian, testicular, and bladder cancers. The compound’s stereochemistry plays a critical role in influencing biological activity and drug resistance profiles, making it important in the design of next-generation platinum therapeutics.